Management of extrapulmonary sarcoidosis: Challenges and solutions

Khalid Al-Kofahi, Peter Korsten, Christian Ascoli, Shanti Virupannavar, Mehdi Mirsaeidi, Ian Chang, Naim Qaqish, Lesley A. Saketkoo, Robert P. Baughman, Nadera J. Sweiss

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Background: Sarcoidosis is a chronic multisystem disease of unknown etiology characterized by noncaseating granulomas that most often involves the lungs, but frequently has extrapulmonary manifestations, which might be difficult to treat in individual patients. Objective: To review different disease manifestations, focusing on extrapulmonary organ systems, and to provide treatment options for refractory cases. Materials and methods: We performed a literature search using Medline and Google Scholar for individual or combined keywords of "sarcoidosis, extrapulmonary, treatment, kidney, neurosarcoidosis, cardiovascular, gastrointestinal, transplantation, musculoskeletal, rheumatology, arthritis, and skin". Peer-reviewed articles, including review articles, clinical trials, observational trials, and case reports that were published in English were included. References from retrieved articles were also manually searched for relevant articles. Results and conclusion: Isolated involvement of a single organ or organ system is rare in sarcoidosis, and thus all patients must be thoroughly evaluated for additional disease manifestations. Cardiac sarcoidosis and neurosarcoidosis may be life-threatening. Clinicians need to assess patients comprehensively using clinical, laboratory, imaging, and histopathological data to recommend competently the best and least toxic treatment option for the individual patient.

Original languageEnglish (US)
Pages (from-to)1623-1634
Number of pages12
JournalTherapeutics and Clinical Risk Management
Volume12
DOIs
StatePublished - Nov 7 2016

Fingerprint

Sarcoidosis
Disease
management
Clinical laboratories
Poisons
etiology
Refractory materials
search engine
Skin
Rheumatology
Granuloma
Arthritis
Imaging techniques
Chronic Disease
Therapeutics
Transplantation
Clinical Trials
Kidney
Lung
Neurosarcoidosis

Keywords

  • Chronic granulomatous diseases
  • Diagnostic tests
  • Immunosuppressive agents
  • Sarcoidosis

ASJC Scopus subject areas

  • Medicine(all)
  • Safety Research
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Chemical Health and Safety
  • Pharmacology (medical)

Cite this

Al-Kofahi, K., Korsten, P., Ascoli, C., Virupannavar, S., Mirsaeidi, M., Chang, I., ... Sweiss, N. J. (2016). Management of extrapulmonary sarcoidosis: Challenges and solutions. Therapeutics and Clinical Risk Management, 12, 1623-1634. https://doi.org/10.2147/TCRM.S74476

Management of extrapulmonary sarcoidosis : Challenges and solutions. / Al-Kofahi, Khalid; Korsten, Peter; Ascoli, Christian; Virupannavar, Shanti; Mirsaeidi, Mehdi; Chang, Ian; Qaqish, Naim; Saketkoo, Lesley A.; Baughman, Robert P.; Sweiss, Nadera J.

In: Therapeutics and Clinical Risk Management, Vol. 12, 07.11.2016, p. 1623-1634.

Research output: Contribution to journalReview article

Al-Kofahi, K, Korsten, P, Ascoli, C, Virupannavar, S, Mirsaeidi, M, Chang, I, Qaqish, N, Saketkoo, LA, Baughman, RP & Sweiss, NJ 2016, 'Management of extrapulmonary sarcoidosis: Challenges and solutions', Therapeutics and Clinical Risk Management, vol. 12, pp. 1623-1634. https://doi.org/10.2147/TCRM.S74476
Al-Kofahi, Khalid ; Korsten, Peter ; Ascoli, Christian ; Virupannavar, Shanti ; Mirsaeidi, Mehdi ; Chang, Ian ; Qaqish, Naim ; Saketkoo, Lesley A. ; Baughman, Robert P. ; Sweiss, Nadera J. / Management of extrapulmonary sarcoidosis : Challenges and solutions. In: Therapeutics and Clinical Risk Management. 2016 ; Vol. 12. pp. 1623-1634.
@article{10e2ae92bd73467db92930d9e986561e,
title = "Management of extrapulmonary sarcoidosis: Challenges and solutions",
abstract = "Background: Sarcoidosis is a chronic multisystem disease of unknown etiology characterized by noncaseating granulomas that most often involves the lungs, but frequently has extrapulmonary manifestations, which might be difficult to treat in individual patients. Objective: To review different disease manifestations, focusing on extrapulmonary organ systems, and to provide treatment options for refractory cases. Materials and methods: We performed a literature search using Medline and Google Scholar for individual or combined keywords of {"}sarcoidosis, extrapulmonary, treatment, kidney, neurosarcoidosis, cardiovascular, gastrointestinal, transplantation, musculoskeletal, rheumatology, arthritis, and skin{"}. Peer-reviewed articles, including review articles, clinical trials, observational trials, and case reports that were published in English were included. References from retrieved articles were also manually searched for relevant articles. Results and conclusion: Isolated involvement of a single organ or organ system is rare in sarcoidosis, and thus all patients must be thoroughly evaluated for additional disease manifestations. Cardiac sarcoidosis and neurosarcoidosis may be life-threatening. Clinicians need to assess patients comprehensively using clinical, laboratory, imaging, and histopathological data to recommend competently the best and least toxic treatment option for the individual patient.",
keywords = "Chronic granulomatous diseases, Diagnostic tests, Immunosuppressive agents, Sarcoidosis",
author = "Khalid Al-Kofahi and Peter Korsten and Christian Ascoli and Shanti Virupannavar and Mehdi Mirsaeidi and Ian Chang and Naim Qaqish and Saketkoo, {Lesley A.} and Baughman, {Robert P.} and Sweiss, {Nadera J.}",
year = "2016",
month = "11",
day = "7",
doi = "10.2147/TCRM.S74476",
language = "English (US)",
volume = "12",
pages = "1623--1634",
journal = "Therapeutics and Clinical Risk Management",
issn = "1176-6336",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Management of extrapulmonary sarcoidosis

T2 - Challenges and solutions

AU - Al-Kofahi, Khalid

AU - Korsten, Peter

AU - Ascoli, Christian

AU - Virupannavar, Shanti

AU - Mirsaeidi, Mehdi

AU - Chang, Ian

AU - Qaqish, Naim

AU - Saketkoo, Lesley A.

AU - Baughman, Robert P.

AU - Sweiss, Nadera J.

PY - 2016/11/7

Y1 - 2016/11/7

N2 - Background: Sarcoidosis is a chronic multisystem disease of unknown etiology characterized by noncaseating granulomas that most often involves the lungs, but frequently has extrapulmonary manifestations, which might be difficult to treat in individual patients. Objective: To review different disease manifestations, focusing on extrapulmonary organ systems, and to provide treatment options for refractory cases. Materials and methods: We performed a literature search using Medline and Google Scholar for individual or combined keywords of "sarcoidosis, extrapulmonary, treatment, kidney, neurosarcoidosis, cardiovascular, gastrointestinal, transplantation, musculoskeletal, rheumatology, arthritis, and skin". Peer-reviewed articles, including review articles, clinical trials, observational trials, and case reports that were published in English were included. References from retrieved articles were also manually searched for relevant articles. Results and conclusion: Isolated involvement of a single organ or organ system is rare in sarcoidosis, and thus all patients must be thoroughly evaluated for additional disease manifestations. Cardiac sarcoidosis and neurosarcoidosis may be life-threatening. Clinicians need to assess patients comprehensively using clinical, laboratory, imaging, and histopathological data to recommend competently the best and least toxic treatment option for the individual patient.

AB - Background: Sarcoidosis is a chronic multisystem disease of unknown etiology characterized by noncaseating granulomas that most often involves the lungs, but frequently has extrapulmonary manifestations, which might be difficult to treat in individual patients. Objective: To review different disease manifestations, focusing on extrapulmonary organ systems, and to provide treatment options for refractory cases. Materials and methods: We performed a literature search using Medline and Google Scholar for individual or combined keywords of "sarcoidosis, extrapulmonary, treatment, kidney, neurosarcoidosis, cardiovascular, gastrointestinal, transplantation, musculoskeletal, rheumatology, arthritis, and skin". Peer-reviewed articles, including review articles, clinical trials, observational trials, and case reports that were published in English were included. References from retrieved articles were also manually searched for relevant articles. Results and conclusion: Isolated involvement of a single organ or organ system is rare in sarcoidosis, and thus all patients must be thoroughly evaluated for additional disease manifestations. Cardiac sarcoidosis and neurosarcoidosis may be life-threatening. Clinicians need to assess patients comprehensively using clinical, laboratory, imaging, and histopathological data to recommend competently the best and least toxic treatment option for the individual patient.

KW - Chronic granulomatous diseases

KW - Diagnostic tests

KW - Immunosuppressive agents

KW - Sarcoidosis

UR - http://www.scopus.com/inward/record.url?scp=84995550192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995550192&partnerID=8YFLogxK

U2 - 10.2147/TCRM.S74476

DO - 10.2147/TCRM.S74476

M3 - Review article

AN - SCOPUS:84995550192

VL - 12

SP - 1623

EP - 1634

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

SN - 1176-6336

ER -